303P EO2401 (EO) therapeutic vaccine for patients (pts) with recurrent glioblastoma (GB): Phase I/II ROSALIE study
Year: 2022
Type: article
Source: Annals of Oncology
Institutions: Dana-Farber Cancer Institute, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut du Cerveau, Vall d'Hebron Hospital Universitari, Universitätsklinikum Tübingen, University of Tübingen, Institut Català d'Oncologia, Duran i Reynals Hospital, Centre Georges François Leclerc, Goethe University Frankfurt, University Hospital Frankfurt, Medizinische Fakultät Mannheim, Heidelberg University, University Hospital Heidelberg, Enterome (France), German Cancer Research Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Roche
OpenAlex ID: W4295819065